VivoSeq
Musculoskeletal

Cervical Ripening

1

Pipeline Programs

5

Active Trials

3

Companies Involved

Cervical Ripening is an early-stage landscape with 1 program across 3 companies. The most active players are Pfizer, Ferring, HUDDA Ahmad.

Pipeline Metrics

Competitive Density

22/100

Pipeline Velocity

11/100

Mech. Concentration

100/100

Completion Rate

76/100

Attrition Rate

16/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Preclinical1
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Trial Status

31

clinical trials

Completed16 · 52%
Unknown status5 · 16%
Terminated4 · 13%
Recruiting3 · 10%
Not yet recruiting1 · 3%
Withdrawn1 · 3%
Other1 · 3%

Trial Activity

31 trials

Pain Control for Cervical Ripening Balloon
Not yet recruiting··Phase 2·NCT07268118·110 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)